The stock of Opko Health Inc (OPK) has gone up by 13.28% for the week, with a 12.40% rise in the past month and a -14.71% drop in the past quarter. The volatility ratio for the week is 5.61%, and the volatility levels for the past 30 days are 5.29% for OPK. The simple moving average for the past 20 days is 10.64% for OPK’s stock, with a -6.21% simple moving average for the past 200 days.

Is It Worth Investing in Opko Health Inc (NASDAQ: OPK) Right Now?

, and the 36-month beta value for OPK is at 1.84. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price suggested by analysts for OPK is $4.42, which is $2.97 above the current market price. The public float for OPK is 414.71M, and currently, shorts hold a 7.21% of that float. The average trading volume for OPK on November 20, 2023 was 2.10M shares.

OPK) stock’s latest price update

Opko Health Inc (NASDAQ: OPK)’s stock price has gone rise by 1.40 in comparison to its previous close of 1.43, however, the company has experienced a 13.28% increase in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-07 that Despite OPKO Health’s (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.

Analysts’ Opinion of OPK

Many brokerage firms have already submitted their reports for OPK stocks, with Barrington Research repeating the rating for OPK by listing it as a “Outperform.” The predicted price for OPK in the upcoming period, according to Barrington Research is $2 based on the research report published on June 29, 2023 of the current year 2023.

OPK Trading at 1.03% from the 50-Day Moving Average

After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.27% of loss for the given period.

Volatility was left at 5.29%, however, over the last 30 days, the volatility rate increased by 5.61%, as shares surge +16.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.83% lower at present.

During the last 5 trading sessions, OPK rose by +14.45%, which changed the moving average for the period of 200-days by +5.40% in comparison to the 20-day moving average, which settled at $1.3207. In addition, Opko Health Inc saw 16.00% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at OPK starting from PFENNIGER RICHARD C JR, who purchase 25,000 shares at the price of $1.30 back on Nov 13. After this action, PFENNIGER RICHARD C JR now owns 300,000 shares of Opko Health Inc, valued at $32,491 using the latest closing price.

FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 500,000 shares at $1.25 during a trade that took place back on Nov 10, which means that FROST PHILLIP MD ET AL is holding 201,956,694 shares at $625,462 based on the most recent closing price.

Stock Fundamentals for OPK

Current profitability levels for the company are sitting at:

The net margin for Opko Health Inc stands at -32.70. The total capital return value is set at -12.93, while invested capital returns managed to touch -17.62. Equity return is now at value -13.51, with -9.70 for asset returns.

Based on Opko Health Inc (OPK), the company’s capital structure generated 19.57 points at debt to equity in total, while total debt to capital is 16.36. Total debt to assets is 14.10, with long-term debt to equity ratio resting at 16.30. Finally, the long-term debt to capital ratio is 13.63.

When we switch over and look at the enterprise to sales, we see a ratio of 1.45, with the company’s debt to enterprise value settled at 0.29. The receivables turnover for the company is 4.85 and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.


In conclusion, Opko Health Inc (OPK) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.